Shanghai Haohai Biological Technology (06826.HK) Releases February 2026 Monthly Return
Bulletin Express
Mar 03
Shanghai Haohai Biological Technology Co., Ltd. reported that its total registered share capital remained at 230.56 million RMB as of February 28, 2026. This comprises 36.51 million H shares, listed under stock code 06826, and 194.05 million A shares, listed on the Sci-tech Innovation Board (SSE: 688366).
The H shares in issue remained at 36.51 million with none held in treasury, and their public float complied with the required threshold. The A shares in issue totaled 190.20 million with 3.85 million shares held in treasury.
The report also mentioned that 580.70 thousand H shares repurchased by the company in December 2025 have yet to be cancelled as of February 28, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.